Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Tops Revenue Estimates
VRCAVerrica Pharmaceuticals(VRCA) ZACKS·2024-08-14 21:56

Verrica Pharmaceuticals Inc. (VRCA) came out with a quarterly loss of 0.31pershareversustheZacksConsensusEstimateofalossof0.31 per share versus the Zacks Consensus Estimate of a loss of 0.43. This compares to loss of 0.21pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof27.910.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.91%. A quarter ago, it was expected that this company would post a loss of 0.54 per share when it actually produced a loss of $0.38, delivering a surprise of 29.63%.Over the last four quarters, the company ...